Icahn School of Medicine at Mount Sinai and Meharry Medical College Announce Partnership To Address Racism In Basic Sciences

New Agreement will provide formal framework to build program capacity and enhance diversity among scientists.


(New York, N.Y. —August 1, 2021)—The Icahn School of Medicine at Mount Sinai and Meharry Medical College in Nashville, Tenn., announced they have entered into an agreement that will address racism and bias in the basic sciences and introduce greater diversity and inclusion.


The memorandum of understanding reflects a broader engagement initiative on the part of Icahn Mount Sinai to collaborate with historically Black medical schools, colleges and universities in a comprehensive, institutional approach.


“We are thrilled to be working with Meharry Medical College, one of our country’s premier historically Black medical colleges. With a strong foundation in health disparities research in critically important areas for the Black population, including sickle cell disease, diabetes, and cancer, Meharry Medical College will be an excellent partner with whom we can share clinical knowledge and enrich each institution’s educational, training, and research enterprise,” said Dennis S. Charney, M.D., Anne and Joel Ehrenkranz Dean of Icahn Mount Sinai and president for academic affairs at Mount Sinai Health System.


Icahn School of Medicine and Meharry Medical College hope the MOU will instill a bi-directional, mutually beneficial, exchange of knowledge, from bench to bedside. Through an emphasis on engagement of faculty, the MOU seeks to foster a series of collaborative educational activities that could include a joint graduate or educational medical education program; research activities to be undertaken by students and faculty; and administrative guidelines allowing students to study at each institution.


Meharry Medical College is the oldest of the only four historically Black medical schools in the U.S., where there are approximately 150 medical schools. Other metrics highlight factors contributing to the shortage of Black physicians and scientists across the country. The Association of American Medical Colleges has consistently pointed to the shortage of Black doctors versus their much greater representation in the population at large. Countless reports have described the barriers that minority doctors and researchers face, including a failure among academic medical centers to mentor underrepresented minority faculty.


“Mount Sinai is a renowned clinical enterprise noted for its innovation and expertise, making it the perfect complement to Meharry’s research and health care efforts. We are honored to collaborate with Icahn School of Medicine at Mount Sinai and are eager to begin developing dynamic research and educational programs that will directly benefit minority communities affected by countless health disparities,” said James E.K. Hildreth Ph.D., M.D., president and CEO of Meharry Medical College.


Reginald W. Miller, D.V..M, dean for research operations and infrastructure at Icahn School of Medicine at Mount Sinai, was charged by Dean Charney to lead the HBCU Engagement Initiative, resulting in the MOU with Meharry. “The MOU provides a framework to work together to attract and support a robust pipeline of Black scientists, bringing structure, scale and intentionality to build upon earlier independent efforts by Sinai faculty to address the underrepresentation of Blacks in medicine,” he said.


“The engagement we envision is a faculty-to-faculty partnership between the two institutions in the form of collaborative grants, shared mentoring of graduate students, post docs and faculty, and joint research projects in areas where there are strong opportunities for synergy,” Miller said. “Through these joint activities, we hope to increase capacity and diversity of the biomedical workforce by lowering barriers to access, and strengthening our mentorship and training models


“Training and mentoring faculty in areas such as diabetes, sickle cell disease, cancer, human genetics and neuroscience will be paramount as we seek to improve our understanding of diseases and how they affect people of African ancestry”.



About the Mount Sinai Health System


The Mount Sinai Health System is New York City’s largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report‘s “Honor Roll” of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty by U.S. News & World Report.


For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.